{"id":7276,"date":"2021-01-04T17:48:30","date_gmt":"2021-01-04T16:48:30","guid":{"rendered":"http:\/\/dubawa.org\/dir\/?p=7276"},"modified":"2021-01-04T17:48:36","modified_gmt":"2021-01-04T16:48:36","slug":"covifor-is-not-a-covid-19-vaccine-not-slated-for-test-in-africa-as-claimed-in-this-viral-message","status":"publish","type":"post","link":"https:\/\/dubawa.org\/dir\/covifor-is-not-a-covid-19-vaccine-not-slated-for-test-in-africa-as-claimed-in-this-viral-message\/","title":{"rendered":"Covifor is not a COVID-19 vaccine, not slated for test in Africa as claimed in this viral message"},"content":{"rendered":"\n<p class=\"has-text-align-justify has-cyan-bluish-gray-background-color has-background wp-block-paragraph\"><strong>Claim: A viral WhatsApp message has claimed that Covifor injection, manufactured by the Indian pharmaceutical company, Hetero, is a COVID-19 vaccine expected to be tested in Africa.&nbsp;<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\"><strong>The message attached the picture of the injectable treatment with the label \u201cNot for Distribution in US, Canada or EU\u201d and added a caption that states \u201cWake up Africa, this is not a cure but a trap to kill you as laboratory trap\u201d.&nbsp;<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-justify has-text-color has-background wp-block-paragraph\" style=\"background-color:#f41216;color:#fff9f9\"><strong>Verdict: False. A fact-check has revealed that Covifor is not a Covid-19 vaccine. It is a treatment for the Covid-19 patients with severe symptoms of the disease and has been available in 127 countries around the world since June, 2020.&nbsp;<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Full Text&nbsp;<\/strong><\/h2>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">A viral WhatsApp message has claimed that Covifor injection, manufactured by the Indian pharmaceutical company, Hetero, is a COVID-19 vaccine expected to be tested in Africa.<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">The message has been circulating on different social media platforms, majorly WhatsApp since September, 2020.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">On Twitter, an account with the name GPAN (@<a href=\"https:\/\/twitter.com\/africarepublic?s=21\" target=\"_blank\" rel=\"noreferrer noopener\">AfricaRepublic<\/a>)&nbsp; <a href=\"https:\/\/twitter.com\/africarepublic\/status\/1301241752892911618?s=21\" target=\"_blank\" rel=\"noreferrer noopener\">posted<\/a> the message with the caption \u201cAfrica must wake up\u201d on September 2, 2020.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">A <a href=\"https:\/\/twitter.com\/africarepublic\/status\/1301241752892911618?s=21\" target=\"_blank\" rel=\"noreferrer noopener\">reply<\/a> to the tweet by Ssembogo Kwame (@SsembogoJohn3) added that \u201cWe\u2019re dying, they want to finish us.\u201d<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">Another <a href=\"https:\/\/twitter.com\/blackgi56617250\/status\/1316413701075996672?s=21\" target=\"_blank\" rel=\"noreferrer noopener\">reply<\/a> by a user with the name blackgirl (@blackgi56617250) said \u201cI tell us this people they think they are very strong&nbsp; but&#8230;no.\u201d&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These replies suggest that many users believed the post as true.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Verification<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Covifor Is Not Covid-19 Vaccine<\/strong>&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">According to the Hetero, Covifor is an injection for the treatment of Covid-19 patients with severe symptoms of the disease but not a vaccine.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">The company, in a <a href=\"https:\/\/www.heteroworld.com\/pdf\/Covifor_Hetero_Healthcare_Press_Release_Final.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">statement<\/a> released on June 24, 2020, said with the Covifor, \u201cwe hope to reduce the treatment time of a patient in a hospital, thereby reducing the increasing pressure on the medical infrastructure, overburdened currently due to accelerating covid-19 infection rates.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">\u201cWe are working closely with the Government and Medical Community to make \u2018Covifor\u2019 quickly accessible to both public and private healthcare settings across the country.\u201d<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">The pharmaceutical company added \u201cCovifor is the first generic brand of Remdesivir which is indicated for the treatment of COVID19 patients in adults and children, hospitalised with severe symptoms of the disease&#8221;.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">\u201cThe drug is available in 100 mg vial (Injectable). It needs to be administered intravenously in a hospital, critical care setting, under the supervision of a registered medical practitioner.&#8221;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Covifor Is Available In Some European Countries&nbsp;<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">Contrary to the claim that Covifor is produced to be tested in African countries, the injectable treatment is sold in some European countries that include Georgia, Armenia, Belarus, etc.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">According to the Gilead <a href=\"https:\/\/www.gilead.com\/purpose\/advancing-global-health\/covid-19\/voluntary-licensing-agreements-for-remdesivir\" target=\"_blank\" rel=\"noreferrer noopener\">agreement<\/a>, remdesivir (generic name for Covifor) was expected to be sold in low and middle income 127 countries around the world.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">\u201cThe countries consist of nearly all low-income and lower-middle income countries, as well as several upper-middle- and high-income countries that face significant obstacles to healthcare access.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">\u201cThe regulatory approval status of remdesivir varies by country, and the distribution of remdesivir within each country listed below is subject to local laws and regulations,\u201d the agreement stated.&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">The agreement added that \u201cthe licenses are royalty-free until the World Health Organization declares the end of the Public Health Emergency of International Concern regarding Covid-19, or until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent Covid-19, whichever is earlier.\u201d&nbsp;<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">There are many Covid-19 vaccines currently being approved by different countries around the world.<\/p>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">&nbsp;The United Kingdom has <a href=\"https:\/\/www.vanguardngr.com\/2020\/12\/uk-approves-oxford-astrazeneca-covid-19-vaccine\/\" target=\"_blank\" rel=\"noreferrer noopener\">approved<\/a> AstraZaneca produced by Oxford University while Biontech-Pfizer\u2019s vaccine is currently being administered in some European countries.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Conclusion<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"has-text-align-justify wp-block-paragraph\">The claim that Covifor is a vaccine produced to be tested in Africa is false. The injectable treatment was produced by an Indian pharmaceutical company and is available in 127 countries around the world.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><em>This fact-check is produced per <a href=\"https:\/\/humangle.ng\/fact-check-covifor-is-not-a-covid-19-vaccine-not-slated-for-test-in-africa-as-claimed-in-this-viral-message\/\" target=\"_blank\" rel=\"noreferrer noopener\">HumAngle<\/a> partnership with the Dubawa 2020 Fellowship to facilitate the ethos of \u201ctruth\u201d in journalism and enhance media literacy in Nigeria&nbsp;<\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Claim: A viral WhatsApp message has claimed that Covifor injection, manufactured by the Indian pharmaceutical company, Hetero, is a COVID-19 vaccine expected to be tested in Africa.&nbsp; The message attached the picture of the injectable treatment with the label \u201cNot for Distribution in US, Canada or EU\u201d and added a caption that states \u201cWake up Africa, this is not a cure but a trap to kill you as laboratory trap\u201d.&nbsp; Verdict: False. A fact-check has revealed that Covifor is not a Covid-19 vaccine. It is a treatment for the Covid-19 patients with severe symptoms of the disease and has been available in 127 countries around the world since June, 2020.&nbsp; Full Text&nbsp; A viral WhatsApp message has claimed that Covifor injection, manufactured by the Indian pharmaceutical company, Hetero, is a COVID-19 vaccine expected to be tested in Africa. The message has been circulating on different social media platforms, majorly WhatsApp since September, 2020.&nbsp; On Twitter, an account with the name GPAN (@AfricaRepublic)&nbsp; posted the message with the caption \u201cAfrica must wake up\u201d on September 2, 2020.&nbsp; A reply to the tweet by Ssembogo Kwame (@SsembogoJohn3) added that \u201cWe\u2019re dying, they want to finish us.\u201d Another reply by a user with the name blackgirl (@blackgi56617250) said \u201cI tell us this people they think they are very strong&nbsp; but&#8230;no.\u201d&nbsp; These replies suggest that many users believed the post as true. Verification&nbsp; Covifor Is Not Covid-19 Vaccine&nbsp; According to the Hetero, Covifor is an injection for the treatment of Covid-19 patients with severe symptoms of the disease but not a vaccine.&nbsp; The company, in a statement released on June 24, 2020, said with the Covifor, \u201cwe hope to reduce the treatment time of a patient in a hospital, thereby reducing the increasing pressure on the medical infrastructure, overburdened currently due to accelerating covid-19 infection rates.&nbsp; \u201cWe are working closely with the Government and Medical Community to make \u2018Covifor\u2019 quickly accessible to both public and private healthcare settings across the country.\u201d The pharmaceutical company added \u201cCovifor is the first generic brand of Remdesivir which is indicated for the treatment of COVID19 patients in adults and children, hospitalised with severe symptoms of the disease&#8221;.&nbsp; \u201cThe drug is available in 100 mg vial (Injectable). It needs to be administered intravenously in a hospital, critical care setting, under the supervision of a registered medical practitioner.&#8221; Covifor Is Available In Some European Countries&nbsp; Contrary to the claim that Covifor is produced to be tested in African countries, the injectable treatment is sold in some European countries that include Georgia, Armenia, Belarus, etc.&nbsp; According to the Gilead agreement, remdesivir (generic name for Covifor) was expected to be sold in low and middle income 127 countries around the world.&nbsp; \u201cThe countries consist of nearly all low-income and lower-middle income countries, as well as several upper-middle- and high-income countries that face significant obstacles to healthcare access.&nbsp; \u201cThe regulatory approval status of remdesivir varies by country, and the distribution of remdesivir within each country listed below is subject to local laws and regulations,\u201d the agreement stated.&nbsp; The agreement added that \u201cthe licenses are royalty-free until the World Health Organization declares the end of the Public Health Emergency of International Concern regarding Covid-19, or until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent Covid-19, whichever is earlier.\u201d&nbsp; There are many Covid-19 vaccines currently being approved by different countries around the world. &nbsp;The United Kingdom has approved AstraZaneca produced by Oxford University while Biontech-Pfizer\u2019s vaccine is currently being administered in some European countries. Conclusion&nbsp; The claim that Covifor is a vaccine produced to be tested in Africa is false. The injectable treatment was produced by an Indian pharmaceutical company and is available in 127 countries around the world. This fact-check is produced per HumAngle partnership with the Dubawa 2020 Fellowship to facilitate the ethos of \u201ctruth\u201d in journalism and enhance media literacy in Nigeria&nbsp;<\/p>\n","protected":false},"author":1,"featured_media":7277,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"hannibal_claim_source":"","hannibal_source_label":"","hannibal_card_color":"blue","_jetpack_memberships_contains_paid_content":false,"footnotes":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"","_twitter_share_type":"","_linkedin_share_type":"","_pinterest_share_type":"","_linkedin_share_type_page":"","_instagram_share_type":"","_medium_share_type":"","_threads_share_type":"","_google_business_share_type":"","_bluesky_share_type":"","_mastodon_share_type":"","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"today","timeOption":"now","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":"absolute"},"_wpsp_active_default_template":true},"categories":[1571,121],"tags":[562,1683,1745],"verdict":[],"ppma_author":[1132],"class_list":["post-7276","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fact-check","category-health","tag-coronavirus","tag-covid-19-vaccine","tag-covifor"],"jetpack_shortlink":"https:\/\/wp.me\/p8R6dE-1Tm","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"authors":[{"term_id":1132,"user_id":0,"is_guest":1,"slug":"aliyu-dahiru","display_name":"Aliyu Dahiru","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/f6697bc146fd37a7454b44c98c24de772ae006fb254928abf7f3c470f6a72557?s=96&r=g","author_category":"","user_url":"","last_name":"","first_name":"","job_title":"","description":""}],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/dubawa.org\/dir\/wp-content\/uploads\/2021\/01\/18428f8f-f0cb-4efe-8a50-ae7233e9b5be.jpg?fit=1200%2C700&ssl=1","_links":{"self":[{"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/posts\/7276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/comments?post=7276"}],"version-history":[{"count":0,"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/posts\/7276\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/media\/7277"}],"wp:attachment":[{"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/media?parent=7276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/categories?post=7276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/tags?post=7276"},{"taxonomy":"verdict","embeddable":true,"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/verdict?post=7276"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/dubawa.org\/dir\/wp-json\/wp\/v2\/ppma_author?post=7276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}